Breadcrumb Home News Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment September 29, 2021 JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment. Previous News Debra DeBruin, PhD, Awarded BENUM Board Member of the Year Announcing the Consortium for Workforce Research in Public Health (CWORPH) Study: POC communities dying from COVID-19 at higher rates than white people
